Key Events This Week
18 May: Stock hits 52-week low at Rs.273 amid continued downtrend
19 May: Downgraded to Strong Sell by MarketsMOJO due to weak fundamentals and technicals
22 May: Week closes at Rs.305.25, up 7.12% for the week
Jun 12, 03:30 PM
BSE+NSE Vol: 3.61 lacs

Bajaj Healthcare Ltd has been downgraded from a Sell to a Strong Sell rating as of 8 June 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite recent positive quarterly financial results, the company’s long-term performance and valuation metrics have raised significant concerns among analysts, prompting a reassessment of its investment appeal.
Read full news article
Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a deteriorating outlook. The company’s MarketsMOJO grade has been downgraded from Sell to Strong Sell as of 8 June 2026, reflecting growing concerns over its price performance and technical trends amid broader market pressures.
Read full news article
Bajaj Healthcare Ltd has experienced a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, reflecting a complex interplay of technical indicators amid ongoing downward price pressure. Despite a recent downgrade to a 'Sell' Mojo Grade, the stock’s technical signals present a nuanced picture that investors should carefully analyse.
Read full news article
Bajaj Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
18 May: Stock hits 52-week low at Rs.273 amid continued downtrend
19 May: Downgraded to Strong Sell by MarketsMOJO due to weak fundamentals and technicals
22 May: Week closes at Rs.305.25, up 7.12% for the week

Bajaj Healthcare Ltd has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 18 May 2026, reflecting deteriorating technical indicators and persistent fundamental challenges. Despite recent positive quarterly earnings, the company’s long-term financial trends and valuation metrics have failed to inspire confidence, prompting a reassessment of its investment appeal within the Pharmaceuticals & Biotechnology sector.
Read full news article
For the third consecutive session, Bajaj Healthcare Ltd has closed lower, culminating in a fresh 52-week low of Rs 273 on 18 Jun 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper, reflecting company-specific pressures.
Read full news article
11 May: Stock opens at Rs.336.90, sharp drop begins
12 May: Downgrade to Strong Sell amid technical and financial concerns
13 May: Upgrade to Sell rating reflecting mixed signals
14 May: Technical momentum shifts to more bearish stance
15 May: Week closes at Rs.284.95, down 15.42% for the week

Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a modest day gain of 0.66%, the stock’s broader technical indicators and price action suggest caution for investors amid persistent downward pressures and mixed signals from key momentum oscillators.
Read full news articleAnnual Secretarial Compliance Report
Intimation for Newspaper Publication
Financial Results for the quarter and financial year ended 31st March 2026
No Upcoming Board Meetings
Bajaj Healthcare Ltd has declared 20% dividend, ex-date: 19 Sep 25
Bajaj Healthcare Ltd has announced 5:10 stock split, ex-date: 28 Sep 21
Bajaj Healthcare Ltd has announced 1:1 bonus issue, ex-date: 09 Apr 19
No Rights history available